Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

GREATVIEW ASEPTIC PACKAGING COMPANY LIMITED ॸߕ̍ༀϞࠢʮ̡

(incorporated in the Cayman Islands with limited liability)

(Stock code: 00468)

ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2021

HIGHLIGHTS

  • • Revenue for the year ended 31 December 2021 increased by 14.0% to RMB3,464.3 million.

  • • Net profit after tax of RMB285.1 million, compared with RMB342.8 million in 2020. Profit significantly impacted by raw material costs and international freight charges.

  • • The Company's business in the PRC was resilient. Sales volume and revenue increased by approximately 19.4% and 13.6% respectively.

  • • Solid progress in international expansion. Sales volume and revenue grew by 22.2% and 14.9% respectively. Revenue at constant currency up 18.1%.

  • • Global shortage in raw material, as well as the cost of international logistics will continue to impact the Group's operations. Management expects that if raw material costs continue to rise and international freight charges remain high, there will be a significant adverse effect on profitability in 2022.

The board (the "Board") of directors (the "Directors") of Greatview Aseptic Packaging Company Limited (the "Company" or "Greatview") is pleased to announce the consolidated financial statements of the Company and its subsidiaries (the "Group") for the year ended 31 December 2021 together with comparative figures for the year ended 31 December 2020 as follows:

The figures in respect of this announcement of the Group's consolidated statement of comprehensive income, consolidated statement of financial position, consolidated statement of changes in equity, consolidated statement of cash flows and the related notes ("financial information") does not constitute the Group's statutory financial statements for the year ended 31 December 2021, but represents an extract from those financial statements. The following financial information, including the comparative figures has been reviewed by the audit committee of the Company (the "Audit Committee") and agreed by the Group's external auditors, PricewaterhouseCoopers ("PwC"), Certified Public Accountants in Hong Kong, to the amounts set out in the Group's draft consolidated financial statements for the year ended 31 December 2021. The work performed by PwC in this respect did not constitute an assurance engagement in accordance with International Standards on Auditing, International Standards on Review Engagements or International Standards on Assurance Engagements issued by the International Federation of Accountants and consequently no assurance has been expressed by PwC on this announcement.

CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME

For the year ended 31 December 2021

Amounts expressed in thousands of RMB except for share data

Year ended 31 December

Note

2021 2020

Revenue

3

3,464,333

3,038,864

Cost of sales

6

(2,766,669)

(2,233,301)

Gross profit

697,664

805,563

Other income

4

60,983

37,291

Other gains/(losses) - net

5

14,742

(15,045)

Impairment of losses on financial assets - net

(5,854)

(11,681)

Distribution expenses

6

(230,931)

(177,713)

Administrative expenses

6

(174,286)

(177,272)

Operating profit

362,318

461,143

Finance income

7

6,029

10,465

Finance costs

7

(8,455)

(15,693)

Finance (costs)/income - net

(2,426)

(5,228)

Profit before income tax

359,892

455,915

Income tax expense

8

(74,820)

(113,152)

Profit for the year

285,072

342,763

Note

Year ended 31 December 2021 2020

Profit attributable to:

Owners of the Company

285,072

342,763

Non-controlling interests

-

-

285,072

342,763

Other comprehensive income:

Item that may be reclassified to profit or loss

Currency translation differences

(68,941)

17,738

Total comprehensive income for the year

216,131

360,501

Total comprehensive income attributable to:

Owners of the Company

216,131

360,501

Non-controlling interests

-

-

216,131

360,501

Earnings per share for profit attributable to equity holders

of the Company (expressed in RMB per share)

- Basic and diluted earnings per share

9

0.21

0.26

CONSOLIDATED STATEMENT OF FINANCIAL POSITION As at 31 December 2021

Amounts expressed in thousands of RMB except for share data

2020

ASSETS

Non-current assets

Property, plant and equipment

10

1,223,700

1,312,236

Right-of-use assets

11

64,001

49,851

Intangible assets

87,265

93,843

Deferred income tax assets

33,807

39,018

Trade receivables

13

27,614

18,957

Prepayments

14

10,984

10,407

1,447,371

1,524,312

Current assets

Inventories

12

798,614

710,735

Trade and notes receivables

13

722,721

573,051

Prepayments

14

37,459

40,556

Other receivables

14

12,219

11,871

Cash and cash equivalents

425,242

577,237

Restricted cash

214,854

183,631

2,211,109

2,097,081

Total assets

3,658,480

3,621,393

EQUITY

Capital and reserves attributable to equity holders of

the Company

Share capital, share premium and capital reserve

15

551,458

600,260

Statutory reserve

296,211

281,325

Retained earnings

1,670,035

1,638,899

Exchange reserve

(97,670)

(28,729)

Total equity

2,420,034

2,491,755

As at 31 December 2021

Note

Note

2020

LIABILITIES

Non-current liabilities

Deferred government grants

59,947

73,173

Lease liabilities

11

11,603

2,316

Deferred income tax liabilities

19,469

21,257

Borrowings

16

5,415

14,044

96,434

110,790

Current liabilities

Deferred government grants

7,933

7,771

Contract liabilities

27,663

35

Trade payables, other payables and accruals

17

792,283

746,379

Income tax liabilities

19,933

41,154

Borrowings

16

283,121

191,525

Lease liabilities

11

11,079

5,206

Derivative financial instruments

-

26,778

1,142,012

1,018,848

Total liabilities

1,238,446

1,129,638

Total equity and liabilities

3,658,480

3,621,393

As at 31 December 2021

This is an excerpt of the original content. To continue reading it, access the original document here.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Greatview Aseptic Packaging Co. Ltd. published this content on 28 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 March 2022 12:50:09 UTC.